Head-to-head · WeighScore
Gimme Care vs Magnolia Regenerative Medicine
The verdict
Gimme Care takes it — 84.6/100 to 66.7/100.
Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Gimme Care | Magnolia Regenerative Medicine |
|---|---|---|
| WeighScore | 84.6/100 | 66.7/100 |
| Grade | B | C |
| Scorecard rank | #17 | #193 |
| Semaglutide | $130/mo | $119/mo (billed monthly; the advertised $99 is a three-month prepay) |
| Tirzepatide | $163/mo | $199/mo (billed monthly; the advertised $179 is a three-month prepay) |
| Coverage | All 50 states | 26 states (including Washington, D.C.) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #17 · B
Strengths
- $130 sema / $163 tirz
- All 50 states, LegitScript-verified
- Both molecules
Where it loses points
- Not the cheapest tier
- Injection-only
- Monitoring detail limited
Graded #193 · C
Strengths
- Publishes an exact state list — 26 states including Washington, D.C. — rather than a nationwide claim it then hedges
- Prices both a month-to-month plan and a three-month prepay for each molecule, and states the totals rather than only a per-month equivalent
- Prices its lab panels openly at $89 and $189 and says plainly that lab costs are not included
- A large priced peptide and hormone catalog sits beside the GLP-1 lines
Where it loses points
- The advertised “starting at $99” and “starting at $179” are three-month prepay figures, not monthly rates
- A first-time patient cannot reach the advertised price at all: answering that this is a first course produces titration plans at $119 and $199 a month
- A third pair of figures for differently named products — semaglutide with B-6 from $109 and tirzepatide with B-6 from $159 — appears on one page and nowhere else
- The Terms' only cancellation channel is an email address at a domain with no mail records, and three FAQ pages route questions to the same address
- All 127 URLs in the site's own sitemap point at a domain that does not resolve
- The Terms describe a pharmacy transfer fee as “one hundred five dollars ($125.00)”, contradicting themselves inside a single clause
- A strict no-refund policy applies, and a $50 non-refundable fee attaches to a missed appointment
- No pharmacy, compounding class, clinician or NPI is named anywhere on the site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 536 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.